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At the present time radiotherapy, surgery and 
chemotherapy are the main methods of treatment of 
malignant tumors. They may be used individually or in 
combination with other methods. The main 
disadvantage of the traditional methods of radiotherapy 
is the fact that ionizing radiation damages not only 
malignant cells but also surrounding healthy tissues. 
There are also tumors resistive to most extensively used 
gamma-radiation and malignant new formations like 
multiform glioblastoma (badly localized form of the 
brain tumor with plenty of branches) and melanoma 
(aggressive form of the skin cancer) which are 
practically incurable and cause the death of about a 
million people a year. Currently methods of treatment of 
malignant tumors with ions accelerated to high energies, 
and neutron methods directed to decrease the harmful 
effect on healthy tissues, are developed in the world.
In theory the ideal method of radiotherapy may 
be the method in which only cancer cells are 
disintegrated, and healthy cells are not affected. The 
method of boron-neutron-capture therapy (BNCT), 
which is essentially a binary radiation method, satisfies 
this ideal best. In BNCT method the source of strong 
ionizing short-range radiation is in the cancer cells. This 
radiation is generated as a result of interaction between 
external thermal neutron field and atoms of 10B (stable 
isotope), with which cancer cells are saturated 
previously. In the reaction 10B(n,á)7Li two short-range 
ions (helium and lithium) are generated which 
disintegrate the cancer cell (Fig.1).
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Fig.1. 
In this reaction the lithium ion may occur both in 
the ground state, and in the excited state with emitting γ-
quanta:
10B + nth        7Li* (0.84 МeV) + 4He (1.47 МeV) + 
γ (0.48 МeV)       93.7%
10B + nth        7Li (1.01 МэВ) + 4He (1.78 МэВ)     6.3%
Path lengths of lithium and helium ions do not 
exceed the average size of a cell. Therefore, only cells 
containing boron atoms are affected. Boron atoms are 
injected to the tumor by pharmacological boron-
containing preparations capable of accumulating only in 
cancer cells. The boron concentration in the tumor of 
about 30ìgm/gm and neutron flux of about 109 n/cm2 is 
necessary for adequate therapy. The cross-section of the 
mentioned reaction on 10B nucleus is thousands times 
higher than cross-sections of 14N(n,p)14C and 1H(n,ã)2H 
undesirable reactions on nitrogen and hydrogen that 
tissues contain.
Hence the BNCT method may be used for 
treatment of badly localized aggressive forms of tumors 
including above mentioned. Selective pharmacological 
preparations find cancer cells and deliver boron there. 
The neutrons interact with boron containing cells and 
destroy them.
The progress of the BNCT method is determined 
by the achievements in the field of creation of the boron 
containing preparations and in creation of the neutron 
sources with the required parameters. Investigations of 
the BNCT method have shown that the irradiation 
immediately by thermal neutrons is not efficient 
because of their small penetrability. The best procedure 
considers an irradiation by epithermal neutrons with 
energies of 0.5eV up to 10 KeV, which better penetrate 
through osseous and soft tissues and thermalize as they 
penetrate through these tissues before reaching the 
tumor.
At the present time most of neutron sources for 
medical investigations of the BNCT method are based 
on the nuclear reactors. Such investigations are being 
carried out at the Brookhaven Medical Research 
Reactor (BMRR), at the Gorgia reactor (GTRR), at the 
Massachusetts Institute of Technology Reactor (MITR), 
at the National engineer laboratory in Idaho (INEL), at 
the PBF reactor in Patten (Netherlands), and so on.
To obtain a beam with appropriate spectral 
neutron characteristics, with a minimal contamination 
by gamma-radiation, thermal and fast neutrons, the 
output devices of these sources are equipped with 
special moderators, reflectors and absorbers. It is 
complicated and frequently expensive devices.
The sources of fast neutrons based on proton 
accelerators are suggested, which also require 
complicated output devices and high beam powers (tens 
and even hundreds kilowatt) [1].
Recently a new version of the neutron source 
was suggested based on proton accelerator with energy 
of 2 MeV possessing a number of advantages in 
comparison with reactor–based sources [2-4]. It was 
suggested to use 7Li(p,n)7Be reaction near the threshold 
for neutron generation. The threshold proton energy in 
this reaction is 1.881 MeV. Despite the fact that cross 
sections of the reaction near the threshold are low, such 
approach possesses some positive properties, which 
compensate partly this disadvantage. Energies of the 
generated neutrons in the threshold region are close to 
epithermal that simplifies considerably the problem of 
moderating and allows us to do it without complicated 
output devices. The neutron flux from the lithium target 
is kinematically collimated and irradiated object may be 
located in several centimeters from the source that 
increases efficiency of use of a neutron beam. The 
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neutron flux is directed to a forward hemisphere and 
radiation protection is considerably simplified in 
comparison with that of the reactor version. The proton 
accelerator for this purpose is compact, simple and 
inexpensive in operation and may be installed 
immediately in hospitals. This condition also is 
important because the number of nuclear reactors 
suitable for BNCT all over the world is limited and 
cannot satisfy with need all requiring in treatment by 
this method. Development and creation of such 
accelerators do not require further development of 
physics and technology of accelerators.
At the University in Idaho the investigations of 
neutron sources for BNCT are being carried out on a 
linear accelerator with RF quadruple focusing (RFQ) 
and on a proton electrostatic accelerator with energy of 
2 MeV [5]. The investigations have shown that for 
BNCT based on these accelerators, the proton currents 
of 3 –5 mA are necessary. Under this condition the 
neutron fluence of 5x1012 n/cm2 is achieved with total 
doze per hour of 2000cGy on a tumor containing 30 µ
gm/gm of 10B, what is necessary for therapy and is 
tolerant for normal tissues. A special lithium target with 
the cooling system is necessary for removal of a heat 
power of 6-10kW. The experimental results and 
mathematical calculations have shown that this source 
can produce neutron beam for BNCT at proton energies 
of 1.91 MeV with the intensity and nominal overall 
effectiveness of those available at research reactors, and 
with lower thermal deposition than in conventional 
accelerator based designs.
We propose to create a proton linear accelerator 
for the BNCT method based on the existing at NSC 
KPTI linear accelerator of multicharge ions (MILAC) 
analogous to that in Idaho. It is supposed to create a new 
accelerating section for energy of 2 MeV with 
alternating phase focusing (APF) and moving bunch 
center that provides considerable capture both in radial, 
and in longitudinal motion. At the first stage it is 
assumed to create an accelerator with the proton current 
of 1-2 mA. Further it will be increased to 5 mA. For 
creation of such accelerator most of the existing 
equipment of MILAC accelerator could be used: RF 
equipment, vacuum system, the basic part of the 
injector, control system, working areas. The choice of 
such scheme of the accelerator is stipulated by large rate 
of acceleration, availability of the ready equipment, 
experience in development and creation of such 
systems, simplicity of manufacturing, greater 
compactness in a comparison with RFQ systems, and 
also existing industrial basis.
The common view of BNCT circuit is shown on 
Fig.2.
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Fig.2. The common view of BNCT circuit.
At the present time in the Ukraine there are no 
neutron sources suitable for the BNCT method. The 
proposed neutron source could be constructed in the 
short time with the minimal financial contribution, and 
to supply beginning of investigations in this field. The 
evaluations show that it can be created during about two 
years, and financial contribution of $ 100,000 is 
necessary for this purpose. At the present time 
Ukrainian medical researchers are taking an active 
interest to the BNCT method which was accepted as the 
most promising in treatment of malignant diseases, 
especially above mentioned. There is a number of large 
medical institutions interested in development of this 
method, and are ready for cooperation in this area.
Creations of a neutron source will need some 
modernizing of existing systems, creation of new 
accelerating section, target device with a system of 
cooling and creation of radiation protection.
The parameters of a designed proton accelerator 
are shown in table.
Table
 Main parameters of linear proton accelerator for BNCT
The name of a parameter and unit
1 Input energy of ions,                         keV 150
2 Output energy of ions,                      keV 1910
3 Mass-to-charge ratio, À/q 1
4 Operating frequency                        ÌHz 150
5 Electric field in gaps, MV/m 8
6 Aperture of drift tubes, mm 16-26
7 Length of accelerating structure,          m 1.2
8 Number of drift tubes 12
9 Number of focusing regions 3
10 Number of bunching regions 4
11 Radial acceptance                 pi mm mrad 2
12 Longitudinal capture,                       deg. 150
13 Energy spread (for ∆Win.=1%)            % 1.5
14 Longitudinal of output bunch            deg 30
15 Pulse RF power                                 kW 200
16 Duty factor                                        % 2.5
17 Average beam current                       mA 1-2
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